World
2020.09.12 05:34 GMT+8

COVID-19: Sinopharm starts phase three trial in Peru

Updated 2020.09.12 05:34 GMT+8

The Chinese pharmaceutical giant Sinopharm has started the third phase of a COVID-19 vaccine trial in Peru. It comes as the number of coronavirus deaths in the country has topped 30,000.

Check out The China Report, our new weekly newsletter. Subscribe here!

Copyright © 

RELATED STORIES